- Filed
- Apr 30, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 21, 2025 | 624.63M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2025 | $30M |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $0 |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $29.78B |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $31.02B |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $200M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $0 |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $141M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $733M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $21.36B |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $17.04B |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $6.18B |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $4.72B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $4.12B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $4.24B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $64.26B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $64.07B |
| Total Assets | Q1 2025 · Mar 31, 2024 | $44.39B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 585.7M sh |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $578M |
| Capex | Q1 2025 · Mar 31, 2024 | $512M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $596M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $1.09 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $1.09 |
| Net Income | Q1 2025 · Mar 31, 2024 | $639M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $1.06B |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $2.9B |
| Revenue | Q1 2025 · Mar 31, 2024 | $4.78B |